Clinical Trial Update: Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FOLFOX + Panitumumab vs 5-FU + Panitumumab in elderly patients with RAS/BRAF wild-type metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-FU + Panitumumab
• FOLFOX + Panitumumab

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Elderly Metastatic Colorectal Cancer Patients | Phase 2 | Status: UNKNOWN